Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Cited In for PMID: 40526879
3 results
Filters applied: . Clear all
Page 1
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.
JCO Precis Oncol. 2025 Jun;9:e2400776. doi: 10.1200/PO-24-00776. Epub 2025 Jun 17.
JCO Precis Oncol. 2025.
PMID: 40526879
Free PMC article.
Immune Checkpoint Inhibitor Therapy in Hormone Receptor-Positive Breast Cancer.
Lin D, Bitar JSL, Ma I, Yuan Y.
Lin D, et al.
Int J Mol Sci. 2025 Dec 18;26(24):12171. doi: 10.3390/ijms262412171.
Int J Mol Sci. 2025.
PMID: 41465595
Free PMC article.
Review.
Item in Clipboard
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data.
Brufsky AM, Hoskins KF, Conter HJ, Kelemen P, Habibi M, Samian L, Rahman RL, Lee L, Dias EC, Hampton R, Sieling BA, Osborne CR, Brown E, Elayoubi JA, Sharma P, Ramadurai J, Matt-Amaral L, Santillan AA, Davis S, Albaneze P, Ramaswamy H, Chmielewski-Stivers N, Menicucci A, Audeh W, Whitworth P, Johnson N, O'Shaughnessy J.
Brufsky AM, et al.
JNCI Cancer Spectr. 2025 Sep 1;9(5):pkaf079. doi: 10.1093/jncics/pkaf079.
JNCI Cancer Spectr. 2025.
PMID: 40796181
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.